A detailed history of Dana Investment Advisors, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 21,596 shares of INSM stock, worth $1.54 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
21,596
Previous 22,976 6.01%
Holding current value
$1.54 Million
Previous $1.54 Million 2.4%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$62.0 - $79.01 $85,560 - $109,033
-1,380 Reduced 6.01%
21,596 $1.58 Million
Q2 2024

Aug 13, 2024

SELL
$22.0 - $69.71 $15,708 - $49,772
-714 Reduced 3.01%
22,976 $1.54 Million
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $207,303 - $241,316
8,060 Added 51.57%
23,690 $642,000
Q4 2023

Feb 07, 2024

BUY
$23.42 - $31.74 $6,206 - $8,411
265 Added 1.72%
15,630 $484,000
Q3 2023

Nov 15, 2023

BUY
$19.86 - $26.93 $305,148 - $413,779
15,365 New
15,365 $387,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Dana Investment Advisors, Inc. Portfolio

Follow Dana Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.